305 related articles for article (PubMed ID: 32436158)
1. Malignant transformation of oral leukoplakia: a follow-up study.
Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
[TBL] [Abstract][Full Text] [Related]
2. The clinical determinants of malignant transformation in oral epithelial dysplasia.
Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
4. Binary and WHO dysplasia grading systems for the prediction of malignant transformation of oral leukoplakia and erythroplakia: a systematic review and meta-analysis.
de Freitas Silva BS; Batista DCR; de Souza Roriz CF; Silva LR; Normando AGC; Dos Santos Silva AR; Silva MAG; Yamamoto-Silva FP
Clin Oral Investig; 2021 Jul; 25(7):4329-4340. PubMed ID: 34050426
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation in a cohort of patients with oral epithelial dysplasia.
Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542
[TBL] [Abstract][Full Text] [Related]
7. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery unit.
Gilvetti C; Soneji C; Bisase B; Barrett AW
Oral Oncol; 2021 Oct; 121():105462. PubMed ID: 34303087
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.
Reibel J
Crit Rev Oral Biol Med; 2003; 14(1):47-62. PubMed ID: 12764019
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
[TBL] [Abstract][Full Text] [Related]
17. Oral epithelial dysplasia: Recognition, grading and clinical significance.
Odell E; Kujan O; Warnakulasuriya S; Sloan P
Oral Dis; 2021 Nov; 27(8):1947-1976. PubMed ID: 34418233
[TBL] [Abstract][Full Text] [Related]
18. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading.
Dost F; Lê Cao K; Ford PJ; Ades C; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):343-52. PubMed ID: 24388536
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.
Brouns E; Baart J; Karagozoglu Kh; Aartman I; Bloemena E; van der Waal I
Oral Dis; 2014 Apr; 20(3):e19-24. PubMed ID: 23521625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
